We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $83.5M
1-Year Est. Return 77.51%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$194M
AUM Growth
-$27.6M
Cap. Flow
-$9.43M
Cap. Flow %
-4.85%
Top 10 Hldgs %
50.04%
Holding
35
New
6
Increased
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.52M
2
MRK icon
Merck
MRK
+$9.39M
3
LIN icon
Linde
LIN
+$9.29M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.04M
5
KLAC icon
KLA
KLAC
+$7.86M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Financials 16.71%
3 Technology 15.69%
4 Energy 13.06%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$123B
$11.6M 5.95%
41,056
-1,490
-4% -$399K
UNH icon
2
UnitedHealth
UNH
$382B
$10.5M 5.41%
20,473
-550
-3% -$276K
LLY icon
3
Eli Lilly
LLY
$1.08T
$10.3M 5.29%
+31,700
New +$9.52M
MRK icon
4
Merck
MRK
$322B
$9.66M 4.97%
+105,965
New +$9.39M
COR icon
5
Cencora
COR
$62B
$9.63M 4.96%
68,096
-2,325
-3% -$356K
AZO icon
6
AutoZone
AZO
$51.3B
$9.41M 4.84%
4,381
-295
-6% -$607K
RTX icon
7
RTX Corp
RTX
$290B
$9.3M 4.79%
96,821
COP icon
8
ConocoPhillips
COP
$144B
$9.3M 4.79%
103,587
-13,180
-11% -$1.36M
CB icon
9
Chubb
CB
$140B
$9.04M 4.65%
45,989
LIN icon
10
Linde
LIN
$236B
$8.55M 4.4%
+29,740
New +$9.29M
LNG icon
11
Cheniere Energy
LNG
$54.2B
$8.52M 4.38%
64,026
-1,850
-3% -$252K
PANW icon
12
Palo Alto Networks
PANW
$256B
$8.29M 4.27%
100,716
-4,890
-5% -$434K
CME icon
13
CME Group
CME
$95.4B
$8.19M 4.21%
40,015
BMY icon
14
Bristol-Myers Squibb
BMY
$129B
$8.12M 4.18%
+105,500
New +$8.04M
FTNT icon
15
Fortinet
FTNT
$112B
$7.64M 3.93%
134,970
-32,845
-20% -$1.95M
KR icon
16
Kroger
KR
$36.7B
$7.61M 3.91%
160,703
CVX icon
17
Chevron
CVX
$382B
$7.56M 3.89%
52,209
-710
-1% -$117K
DE icon
18
Deere & Co
DE
$165B
$7.51M 3.86%
25,068
KLAC icon
19
KLA
KLAC
$222B
$7.46M 3.84%
+233,750
New +$7.86M
AJG icon
20
Arthur J. Gallagher & Co
AJG
$69.1B
$7.42M 3.82%
+45,500
New +$7.55M
BMO icon
21
Bank of Montreal
BMO
$123B
$6.7M 3.45%
69,658
AAPL icon
22
Apple
AAPL
$4.97T
$6.38M 3.28%
46,676
EIDO icon
23
iShares MSCI Indonesia ETF
EIDO
$466M
$1.86M 0.96%
83,080
SE icon
24
Sea Limited
SE
$66.4B
$1.45M 0.75%
21,700
MS icon
25
Morgan Stanley
MS
$319B
$1.12M 0.58%
14,777

Similar funds

Marvin & Palmer Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Marvin & Palmer Associates held 35 positions worth $194M, down 12% from $222M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Marvin & Palmer Associates withdrew a net $9.43M in Q2 2022, closing 8 positions and reducing 10 holdings. Its most notable exit was Ameriprise Financial, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marvin & Palmer Associates opened a new position in Eli Lilly worth $10.3M.

  • Marvin & Palmer Associates's largest Q2 2022 buy was Eli Lilly: 31,700 shares worth $10.3M.
  • Marvin & Palmer Associates's biggest Q2 2022 reduction was Fortinet, cutting an estimated $1.95M.
  • Marvin & Palmer Associates fully exited Ameriprise Financial in Q2 2022, selling an estimated $11.8M.
  • Marvin & Palmer Associates's ten largest holdings make up 50% of its $194M portfolio in Q2 2022.
  • Marvin & Palmer Associates opened 6 new positions and closed 8 in Q2 2022.
  • Marvin & Palmer Associates's portfolio value fell 12% quarter-over-quarter to $194M.

Based on Marvin & Palmer Associates's 13F filing for Q2 2022, filed 9 Aug 2022.